Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Microbial Properties Predicting a Worsening Course of Fatty Liver Disease

NCT03748511 is registered in ClinicalTrials.gov with HaEmek Medical Center, Israel as lead sponsor.

NCT NCT03748511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03748511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Microbial Properties Predicting a Worsening Course of Fatty Liver Disease
Lead sponsor
HaEmek Medical Center, Israel
Phase
Observational
Overall status
Terminated
Start date
March 5, 2019
Completion date
September 8, 2022
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with fatty liver disease